Canopy Growth Corp 8-K

What Happened
Canopy Growth Corporation announced on March 16, 2026 (via Form 8-K and a press release) that it completed its previously announced acquisition of all issued and outstanding common shares of MTL Cannabis Corp. The Arrangement, governed by an arrangement agreement dated December 14, 2025 (as amended), was completed by way of a plan of arrangement under the Canada Business Corporations Act.

Key Details

• Consideration to MTL shareholders: 0.32 Canopy Growth common share plus C$0.144 cash per MTL share.
• Aggregate issuance: approximately 41.2 million Canopy Growth Shares and about $18.5 million in cash issued to former MTL shareholders.
• Additional issuance: 2,956,391 Canopy Growth Shares issued to certain former shareholders of Montreal Cannabis Medical, Inc. (MC) in exchange for a release of prior obligations; these shares are subject to an 18-month transfer restriction.
• Disclosure filings: Item 7.01 Reg FD disclosure (press release attached as Exhibit 99.1) and Item 8.01 Other Events confirming closing.

Why It Matters
The transaction increases Canopy Growth’s share count by roughly 44.2 million shares (41.2M to MTL shareholders plus 2.96M to MC-related shareholders), which is material for existing shareholders because it dilutes current equity. The cash component ($18.5M) affects the company’s near-term liquidity. The 18-month restriction on the shares issued to former MC shareholders limits immediate resale pressure from that tranche. Investors should note this was a completed acquisition (not just announced), and details are disclosed in the company’s 8-K and attached press release.